Sketchy GLP batches?

Quirky_Goals

Quirky_Goals

Active member
Okay, so much to think about! Gotta break it down. That article mentioned unstable compounded stuff causing immune reactions. Is that really a thing? Could that explain different experiences with different batches? Are grey peptides actually unstable? Should we be filtering them to avoid reactions?
 
Gemini returned these two studies about long-term effects of tirzepatide (Mounjaro/Zepbound):

One trial followed folks for about 3.4 years. The highest dose group (15mg) kept off almost 23% of their weight. And in people with pre-diabetes, it cut the risk of getting type 2 diabetes way down, like 94% compared to placebo. Almost everyone on the drug stayed diabetes-free.

Another tracked over 13,000 patients with type 2 diabetes and heart issues for around 4 years. Tirzepatide worked as well as other treatments for preventing heart problems. It also lowered the chance of dying from any cause (8.6% vs 10.2%). Plus, it seemed to help kidney function.

Side effects were mostly stomach stuff, like feeling sick or having diarrhea. Serious risks, like pancreatitis, were rare, under 1% of users. Still not safe for people with certain thyroid cancer histories.
 
GLP-1s have been around a long time. Sema's patent is almost up. I'm betting the long-term effects are mostly good news.
 
Gemini says these are the 4-year study findings on tirzepatide and atherosclerosis:

Studies in late 2025/early 2026 confirmed tirzepatide gives strong protection against heart disease. Seems to be from losing weight plus direct effects on the blood vessels.

One trial showed tirzepatide was as good as another drug at preventing major heart events. They saw a lower risk of death. The drug might also help stabilize plaque buildup and repair blood vessel linings. It also lowered inflammation.

Based on 3-year data, tirzepatide significantly lowered the predicted risk of heart issues. Participants saw their risk drop by almost 10%, while the placebo group's risk went up.
 
That "exposure to unstable compounded formulations" line is just the usual bashing of compounded GLP-1s. Probably paid for by Eli Lilly. I doubt peptides are any less stable than brand name stuff. I've been using compounded tirz for over a year, and it works great, even better than Zepbound.

And about "long-term" studies... what are people expecting? Clinical trials won't follow patients for decades. The real long-term study is just millions of patients using the meds. Sema was first prescribed in late 2017 for diabetes... that's almost a decade of real-world data.
 
Those studies miss one huge benefit – alcohol control! Since starting Reta, I don't even crave a drink. Had one beer at a party, took forever to finish. Alcohol just isn't a factor anymore. Heard similar stories about meth and other addictions. I'll stay on Reta for that reason alone.
 
I've been seeing talk about grey market peptides causing reactions from contamination. Like itching, redness, or the stuff just not working. Some are suggesting filtering them. What do you think?
 
Lean_IRL said:
My gallbladder went haywire when I lost around 40 lbs in under 2 months. Now it's barely functioning. Surgery soon.
Click to expand...

That's pretty common with any big diet, GLP-1s, or even weight loss surgery if you drop a lot of weight fast.
 
We should filter grey market stuff anyway, 'cause we have no clue about the labs. Filtering costs next to nothing. Don't even need the "scary mutagenics" reason; I'm sold at "we don't know if they checked for bugs."
 
I appreciate the chatbot info, but "AI" doesn't think critically and gives false confidence. "Safety" is just a word to it. It finds studies with GLP and "safety" then paraphrases them, without understanding the context.

A diabetes study can't tell you about long-term safety for GLP use in non-diabetics. Safety is determined by comparing bad things happening to people using the GLP versus bad things happening to the control group (poorly controlled diabetics).

It should have answered: GLP drugs are safer than living with uncontrolled diabetes. That's good, but doesn't tell us if they're safe for non-diabetics.
 
The answer is right in the abstract:

Duration of Follow-up The duration of the trial was 72 weeks.

"Long-term" usually means 5-10 years or more, not a year and a half.

I'm not saying GLPs are unsafe. I just think nobody knows the answer to the original question. Claiming otherwise is misleading.

This is how drug approvals work. Studying GLPs for a decade before release would be too expensive and delay access. Population-level health data is monitored after approval. If a safety signal emerges, it gets investigated and the drug might be pulled.
 
We know plenty. I've prescribed GLP-1s to my diabetes patients for over 15 years, and they've been around for maybe 20 years even?
 
If I'd known my gallbladder was messed up BECAUSE of the diet, I would have tried to change things and save it. I got so much bad info! I had like ten more attacks before finally getting surgery. Couldn't face another couple of hours of that pain. Now I tell people, "I'm partially human now!"
 
So many people are having good results and keeping the weight off. Maybe the length of the studies isn't as important as just seeing that people can actually change their lives. I saw one person dropped nearly 100 lbs!
 
Quirky_Goals said:
So many people are having good results and keeping the weight off. Maybe the length of the studies isn't as important as just seeing that people can actually change their lives. I saw one person dropped nearly 100 lbs!
Click to expand...

That's amazing! I'm seeing more guys posting about their success too. One guy went from 312 to 185. I bet he feels like a new person!
 
You must log in or register to reply here.
Back
Top